Literature DB >> 17406041

Breast pathology in complications associated with polyacrylamide hydrogel (PAAG) mammoplasty.

K M Leung1, Gary P S Yeoh, K W Chan.   

Abstract

OBJECTIVE: To study the tissue pathology of breast lesions associated with hydrophilic polyacrylamide gel injection augmentation mammoplasty.
DESIGN: Retrospective study.
SETTING: Private anatomical pathology practice, Hong Kong. PATIENTS: Eight patients who underwent lumpectomy of the breast due to complications of hydrophilic polyacrylamide gel injection for augmentation mammoplasty. MAIN OUTCOME MEASURES: Identification of hydrophilic polyacrylamide gel in breast tissue and associated pathological changes.
RESULTS: We reviewed the pathological changes in breast tissue associated with hydrophilic polyacrylamide gel injection in eight cases retrieved from our archive. Microscopically, the hydrophilic polyacrylamide gel appeared as pools of pale violet gelatinous material of variable size, between the interstices of connective tissue and fat cells. The larger pools were often surrounded by cellular reactions consisting of histiocytic cells and foreign body-type multinucleated giant cells. Inflammatory reaction featuring infiltration by lymphocytes and plasma cells in the adjacent breast tissue was observed in samples from four patients, and a sample from another patient showed acute inflammation with abscess formation. There was no evidence of abnormal cellular proliferation, atypia or malignant change in the stromal connective tissue or ductal-acinic epithelial components of the breast tissue.
CONCLUSIONS: Hydrophilic polyacrylamide gel injection for augmentation mammoplasty can give rise to a breast lump and inflammation. Pathologically, this complication is associated with fibrosis, foreign body reaction, and inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406041

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  9 in total

1.  Treatment for displacement of PAAG mixture after injection augmentation mammoplasty.

Authors:  Liang Chen; Liu Sha; Shu-Peng Huang; Shi-Rong Li; Zhen-Xiang Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Polyacrylamide hydrogel injection for breast augmentation: another injectable failure.

Authors:  Zhenxiang Wang; Shirong Li; Lingli Wang; Shu Zhang; Yan Jiang; Jinping Chen; Donglin Luo
Journal:  Med Sci Monit       Date:  2012-06

Review 3.  Managing Complications of Fillers: Rare and Not-So-Rare.

Authors:  Eckart Haneke
Journal:  J Cutan Aesthet Surg       Date:  2015 Oct-Dec

4.  Breast contracture and skin sclerosis following 20 years of polyacrylamide hydrogel migration in a patient with familial vitiligo: a case report.

Authors:  Bin Wang; Jiaming Sun; Jing Tong
Journal:  BMC Surg       Date:  2021-02-26       Impact factor: 2.102

5.  Clinicopathological Analysis of 90 Cases of Polyacrylamide Hydrogel Injection for Breast Augmentation Including 2 Cases Followed by Breast Cancer.

Authors:  Ying Yang; Shumo Li; Jia He; Xian Zhao; Wei Chen; Xiaoming Dai; Liu Liu
Journal:  Breast Care (Basel)       Date:  2019-05-29       Impact factor: 2.860

6.  Volumetric measurement of polyacrylamide hydrogel injected for breast augmentation using magnetic resonance imaging.

Authors:  Jiejie Hu; Chunjun Liu; Lin Chen; Wenshan Xing; Jie Luan
Journal:  Exp Ther Med       Date:  2013-12-17       Impact factor: 2.447

7.  Delayed active bleeding after radical evacuation of injected polyacrylamide hydrogel and immediate implant based breast reconstruction.

Authors:  Min-Ling Chen; Jin-Lan Liu; Shen-Jung Hsu; Chang-Cheng Chang
Journal:  Springerplus       Date:  2016-08-30

8.  Treatment of complications from polyacrylamide hydrogel breast augmentation.

Authors:  Wang Wei
Journal:  Exp Ther Med       Date:  2016-05-09       Impact factor: 2.447

9.  Repeated lumps and infections: A case report on breast augmentation complications.

Authors:  Ming-Xuan Zhang; Shi-Yan Li; Li-Long Xu; Bo-Wen Zhao; Xiao-Yan Cai; Guang-Lan Wang
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.